TMVR development
HighLife has raised €44M across 2 funding rounds from 3 investors, most recently a Series B round in Jan 2019. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2019-01-01 | Series B | €32M | Andera Partners,Venture Partners | View deal → |
| 2017-10-27 | Other | €12M | Sofinnova Partners | View deal → |
